CLINICAL EVENTS CALENDAR
Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.
Clinical Review
Venous Laser Updates: New Wavelength or New Fibers?
Introduction
Since the introduction of endovenous lasers (EVL) in the early 2000s, procedure methodologies, as well as device technologies, have evolved extensively in the endeavor to improve treatment outcomes. As each novel parameter has been studied, new data have enabled the venous ablation community to acquire an enhanced understanding of the laser’s mechanism of action. The primary subject matter in EVL studies has routinely included one or a combination of the following: laser fiber vein-wall contact,1,2 linear endovenous energy density (LEED),3,
Cardiogenic Shock: From Reperfusion to Revascularization and Hemodynamic Support
Amar R. Chadaga, MD, Jamil B. Dihu, MD, Timothy A. Sanborn, MD
Abstract
Cardiogenic shock represents the most ominous challenge of acute myocardial infarction (AMI), with an incidence of 8–9% and a mortality rate approaching 50%. The majority of cases of cardiogenic shock are secondary to AMI complicated by left ventricular failure leading to refractory hypoperfusion and hypotension. Placement of an intra-aortic balloon pump (IABP) and primary percutaneous coronary intervention (PCI), particularly in young patients, remain the America
Management of Common Femoral Artery and Bifurcation Diseases
pg. E27 - E30
__________________________
Introduction and Epidemiology
Isolated atherosclerotic involvement of the common femoral artery (CFA) and its bifurcation are rare and reports consisting large patient series are unavailable. The CFA is usually involved as a continuum with the atherosclerosis of the proximal (iliac) or distal (femoro-popliteal) arterial segments. CFA and its bifurcation are critical segments of the lower-limb arterial tree, exemplified by the development of acute and limb-threatening ischemia when it is occluded with a thrombotic or thrombo-
Impact of Technique and Device Selection on Clinical Outcomes in Carotid Artery Stenting
pg. E20 - E26
_________________________
Introduction
Each year about 780,000 people experience a new or recurrent stroke, accounting for 17% of cardiovascular deaths.1 Approximately 80% of strokes are caused by focal cerebral ischemia and the remaining 20% are caused by hemorrhage.2 Almost 20% of ischemic strokes result from carotid artery stenosis.3,4 Various options for the management of carotid artery stenosis include medical therapy, carotid artery endarterectomy (CEA) and carotid artery stenting (CAS). CEA has been established as a gold-standard treatment for ca
Intracranial Stent-assisted Revascularization for Acute Ischemic Stroke
From *University at Buffalo, State University of New York, Buffalo, New York and §Millard Fillmore Gates Hospital, Kaleida Health; Departments of Neurosurgery & Radiology and Toshiba Stroke Research Center, Buffalo, New York.
Manuscript submitted July 29, 2009, provisional acceptance given August 17, 2009, accepted September 9, 2009.
Correspondence: L. Nelson Hopkins, MD, University at Buffalo, State University of New York, Neurosurgery, 3 Gates Circle, Buffalo, NY 14209. E-mail: lnhbuffns@aol.com
Disclosures: Dr. Hopkins receives research support from Toshiba; serves as a consultant
IVC Filters: Indications and Evidence
Abstract
The role of anticoagulants in the treatment of venous thrombo-embolic disease is well established. The use of inferior vena cava filters as a second line treatment is increasing, most recently with the popularity of of retrievable filters. However, the indications and evidence for their safety and efficacy are not clear-cut. There are few absolute indications. The majority of evidence originates from single-center series studying a preferred few genres of filters. Generalizability and meta-analysis are difficult. Important questions remain to be answered, particularly regard
Bare-Metal Versus Drug-Coated Intracoronary Stents in Clinical Practice: Are There Guidelines?
Introduction
The development of bare-metal stents (BMS) and optimal post-procedure antiplatelet therapy in the mid 1990s resulted in marked reductions in acute and subacute stent thrombosis, bleeding complications, negative remodeling, and acute vessel recoil, and a consequent dramatic rise in procedural success. Yet, intermediate-term outcomes remained hampered by restenosis from aggressive neointimal hyperplasia. The advent of drug-coated stents, which impede the growth of neointima while maintaining the strengths of BMS, heralded their widespread utilization to approximately 90% o
Does Microparticle Size Affect Bland Embolization Outcomes of Local Treatment for Liver Malignancies?
Introduction
Treatment options for primary liver tumors (i.e., hepatocellular carcinoma or HCC) and metastatic liver neoplasms have increased in the past decade in response to the incidence of these tumors; HCC is the most common primary liver cancer, while liver tumors are the sixth most common cancer and the third most common cause of cancer-related death globally.1,2 The incidence of liver cancer in the United States and Western Europe is increasing.3,4 Liver metastases from colorectal cancer (CRC) develop in 50% of patients.5
While liver resection remains the gold standard in
Gene Therapy in Critical Limb Ischemia
authors:
1Hong H. Keo, MD, 2Alan T. Hirsch, MD, 1Iris Baumgartner, MD, 3Sigrid Nikol, MD,
2Timothy D. Henry, MD
________________________________
Abstract
Critical limb ischemia (CLI) represents the most severe stage of atherosclerotic lower extremity peripheral artery disease (PAD), and CLI prevalence is expected to increase as the population ages. The current standard of care for CLI relies on direct revascularization, either by endovascular techniques or open surgical approaches, as there are few effective medical treatments for this condition. Therapeutic angi
Interventional Treatment Options for Small Saphenous Varicose Veins
authors:
Caroline D. Rodd, MD, FRCS, Alison M. Young, MBBS, Jonothan J. Earnshaw, DM, FRCS
___________________________
Introduction
Varicose veins are common, and affect nearly a third of adults in Western societies. Although women present more frequently for treatment, Lee et al observed a significantly higher age-adjusted prevalence of varicose veins in men (40% vs. 32% in women).1 Patients present with a variety of symptoms that they attribute to their varicose veins, including pain, heaviness, burning, itching, superficial thrombophlebitis, skin changes, and
Vascular Disease Blogs
VDM Monthly Poll
Digital Supplements
Terumo Clinical Case Update This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.
Vascular Disease News Wire
- Friday, March 12, 2010 - 14:30
- Friday, March 12, 2010 - 14:27
- Friday, March 12, 2010 - 14:20
Anytown, California
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.
